Search Count: 10
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Identification Of Small-Molecule Binding Sites Of A Ubiquitin-Conjugating Enzyme-Ube2T Through Fragment-Based Screening
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2024-02-28 Classification: LIGASE Ligands: V23, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-02-28
Ligands: V23, EDO
 |
Identification Of Small-Molecule Binding Sites Of A Ubiquitin-Conjugating Enzyme-Ube2T Through Fragment-Based Screening
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-28 Classification: LIGASE Ligands: V2R |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-02-28
Ligands: V2R
 |
Identification And Characterization Of Inhibitors Covalently Modifying Catalytic Cysteine Of Ube2T And Blocking Ubiquitin Transfer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2023-11-29 Classification: LIGASE/INHIBITOR Ligands: V6C, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-11-29
Ligands: V6C, EDO
 |
Identification And Characterization Of Inhibitors Covalently Modifying Catalytic Cysteine Of Ube2T And Blocking Ubiquitin Transfer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2023-11-29 Classification: LIGASE/INHIBITOR Ligands: V5L, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-11-29
Ligands: V5L, EDO
 |
Crystal Structure Of A Phosphotyrosine Binding Domain
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2012-01-25 Classification: LIGASE Ligands: ZN |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2012-01-25
Ligands: ZN